I have probably held for as long as you have. Started with 50 shares and now sit at 35,000. The light is finally at the end of the tunnel.
Funny how everyone is trying to glom onto the KBIO pop.
Clown, the 20% is pure profit to Geron ... a royalty. Do you know what "royalty" means ?? LOL It's not 20% of the revenue is Geron revenue as you are spinning Chipppppiieeee !!! Grow up.
Lot's of cluelessness going on here. Geron gets 20+% percent royalty. That's not 20% of the revenue.. its $20 of every $100 sold goes straight into Geron's pocket as profit (not revenue)
"I need concrete info regarding MF and MDS" If you wait until then the PPS will be significantly higher. That's the gamble that people are here for. Buy the stock before there is 100% certainty and reap the rewards if it does get FDA approval. If you want a guaranteed return put your money in a CD.
This is the Dr. T Mayo study that Geron has already said was incorrectly updated to say it was recruiting. It hasn't been recruiting for some time now.
Exactly , there is no drug with the same mode of action as Imetelstat. Unlike INCY where competitive Jak inhibitors are coming on line, there is absolutely nothing like Imetelstat even preclinical. It's in a class of its own.
No doubt. With the MDS trial plans for phase 3/pivotal trial laid out it was definitely the most material information revealed in a Q CC yet.
Get read for the ride.
Yea, Hillary going after a drug company that jacked the price of a 60 year old drug from $50 to $700 a pill is just awful. LOL ... Then we have the same clowns supporting this price increase that complain about health insurance costs.
Maybe he's assuming we will have 10% inflation :)
I certainly hope he's not that clueless about what a normal growth rate is
Some people talk about their incredible high school athletic career the rest of their lives. The highlight of your life appears to be the high school debate club.
bp, you should post this on the INCY MB to make sure he sees it ... and since he came by and dropped a turrd on the GERN MB
I agree. Until now Geron has just been another small biotech with promising early stage results.